Publications by authors named "Christopher J Paddon"

Claim this Profile
E
Exploring yeast glucans for vaccine enhancement: Sustainable strategies for overcoming adjuvant challenges in a SARS-CoV-2 model.
João Azevedo-Silva, Manuela Amorim, Diana Tavares-Valente, Pedro Sousa, Raodoh Mohamath, Christopher J Paddon

Eur J Pharm Biopharm· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Kilo-Scale GMP Synthesis of Renewable Semisynthetic Vaccine-Grade Squalene.
Karl J Fisher, Laura Shirtcliff, Greg Buchanan, Andrew W Thompson, Frank X Woolard, Christopher J Paddon

Org Process Res Dev· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coproduction of Phase-Separated Carotenoids and β-Farnesene as a Yeast Biomass Valorization Strategy.
Yoseph Tsegaye, Phoebe Yeh, Victor Holmes, Matthew Jones, Alexander Kilbo, Christopher J Paddon

ACS Synth Biol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semi-synthetic terpenoids with differential adjuvant properties as sustainable replacements for shark squalene in vaccine emulsions.
Karl J Fisher, Robert Kinsey, Raodoh Mohamath, Tony Phan, Hong Liang, Christopher J Paddon

NPJ Vaccines· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.
Emily A Voigt, Alana Gerhardt, Derek Hanson, Madeleine F Jennewein, Peter Battisti, Christopher J Paddon

NPJ Vaccines· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A self-amplifying RNA vaccine against COVID-19 with long-term room-temperature stability.
Emily A Voigt, Alana Gerhardt, Derek Hanson, Madeleine F Jennewein, Peter Battisti, Christopher J Paddon

NPJ Vaccines· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli.
Hiroko Tsuruta, Christopher J Paddon, Diana Eng, Jacob R Lenihan, Tizita Horning

PLoS One· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis